Iricor
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2900 Boul. Édouard-montpetit, Montreal, ...Phone Number
+51 43436111Website
www.iricor.caRevenue
$9.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Iricor
Founded in 2008 by the Institute for Research in Immunology and Cancer at the University of Montreal, IRICoR is a key player in Quebec's life sciences ecosystem. Its mission is to accelerate the discovery, development, and commercialization of innovative therapies in oncology, immunotherapy, and rare diseases. IRICoR establishes strategic partnerships with the biopharmaceutical industry and creates spin-off companies to transform academic research projects into new therapies for patient benefit. The organization provides essential financial support and access to specialized research expertise and infrastructure, facilitating the drug development process from early project phases.Explore more
Iricor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Iricor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Iricor launches new products
Earning: See what the market has to say on Iricor recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Iricor
Click to see if Iricor had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Iricor has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Iricor has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Iricor is spiking on competitors!
Iricor, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Iricor
Compare insights from companies similar to Iricor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Iricor is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Iricor is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Iricor.
Iricor Tech Stack
A closer look at the technologies used by Iricor
See more technologies
Iricor News & Media
Epitopea Closes USD $31M Pre-Series A Financing
Epitopea, a Cambridge, UK- and Montreal, Canada-based cancer immunotherapeutics company, raised USD $31M in Pre-Series A funding. Backers included Investissement Québec, adMare BioInnovations, Jonathan Milner, existing investors Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital, Fonds de Solidarité FTQ, the Harrington Discovery Institute, IRICoR and Novateur Ventures. The company intends to use the funds […] The post Epitopea Closes USD $31M Pre-Series A Financing appeared fiELIZABETH DOUVILLE APPOINTED PRESIDENT AND CHIEF EXECUTIVE ... - Yahoo Finance
The members of IRICoR's Board of Directors are proud today to announce the appointment of Elizabeth Douville, Ph.D., ICD.D, to the position of President and Chief Executive Officer of the organization. This appointment comes after Dr. Nadine Beauger, Ph.D., MBA, informed the members of the Board of Directors of her decision to leave the position of President and Chief Executive Officer of IRICoR after 14 remarkable years with the organization.Ipsen, Université de Montréal and IRICoR broaden existing oncology partnership, with an exclusive license agreement and two new discovery-stage programs
Ipsen, Université de Montréal and IRICoR broaden existing oncology partnership, with an exclusive license agreement and two new discovery-stage programs
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Iricor
Sign Up For FreeTo access detailed company insights
Founded in 2008 by the Institute for Research in Immunology and Cancer at the University of Montreal, IRICoR is a key player in Quebec's life sciences ecosystem. Its mission is to accelerate the discovery, development, and commercialization of innovative therapies in oncology, immunotherapy, and rare diseases. IRICoR establishes strategic partnersh... Read More
